Complete Response Letter

Lemtrada US rejection snarls Sanofi

Lemtrada US rejection snarls Sanofi

By

The firm has vowed to appeal an FDA rejection that otherwise complicates its bid to expand in multiple sclerosis.

Janssen gets diabetes CRL

The FDA wants more data for the proposed canagliflozin-metformin medication mix.

Email Newsletters